The Genome Technology Center serves the Dangoor Centre for Personalized Medicine by providing the Dangoor Centre’s researchers genomic technology platforms and protocols which are critical for understanding the structure of individual patients’ genomic profiles, discovering potential biomarkers, and identifying the drugs or therapies that might work for each patient.
The Genome Technology Center (GTC) offers professional guidance and hands-on expertise in:
Genome library creation
Next Generation Sequencing analysis for biomarkers in patient samples
Bioinformatic analysis of sequencing results
The Genome Technology Center (GTC) owns and operates state-of-the-art sequencing platforms, including the HiSeq2500 and MiSeq. The GTC has also formulated unique protocols for the optimal sequencing of:
RNA strands (RNA-Seq)
Protein binding sites (ChIP-Seq)
White blood cell priming (Immuno-Seq)
For more information on the Genome Technology Center, visit the GTC’s website.
For additional information on the equipment operated by the GTC, see the Scientific Equipment Center’s page on the Genomic Center.
Neuroscience research projects concentrating on whole genome epigenetic profiling of the human autistic brain, to understand the molecular foundations of Autistic behavior.
Immunological studies directed towards the elucidation of the genetic background and its effect on infectious diseases.
Developing methods that will expand our understanding of the influence of the human Microbiome on health and disease.
Utilizing small-RNA extraction from plasma and serum to identify early biomarkers in acute coronary syndrome.
Sequencing human tumors to identify the optimal drug for these patients and identify the molecular basis for drug resistance.